Julian Rodriguez-Suarez
Overview
Explore the profile of Julian Rodriguez-Suarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rubio-Granda A, Secades-Romero M, Rodriguez-Suarez J, Murias-Loza S
Acta Paediatr
. 2024 May;
113(8):1972-1973.
PMID: 38761031
No abstract available.
2.
Rodriguez-Suarez J, Solis-Sanchez G, Riano-Galan I
Nutrients
. 2023 Nov;
15(21).
PMID: 37960285
Growth in the neonatal period is critical for the neurodevelopment of the individual, both in low- and middle-income countries [...].
3.
Aristegui J, Alfayate-Miguelez S, Carazo-Gallego B, Garrote E, Diaz-Munilla L, Mendizabal M, et al.
Hum Vaccin Immunother
. 2022 Apr;
18(5):2046961.
PMID: 35435807
Rotavirus (RV) is the most common cause of severe gastroenteritis (GE) in infants and young children worldwide and is associated with a significant clinical and economic burden. The objective of...
4.
Claramunt D, Gil-Pena H, Fuente R, Garcia-Lopez E, Frias O, Ordonez F, et al.
Pediatr Res
. 2017 Oct;
82(5):888.
PMID: 29040261
This corrects the article DOI: 10.1038/pr.2017.95.
5.
Claramunt D, Gil-Pena H, Fuente R, Garcia-Lopez E, Frias O, Ordonez F, et al.
Pediatr Res
. 2017 Apr;
82(1):148-154.
PMID: 28376076
BackgroundIn a model of growth retardation secondary to chronic kidney disease (CKD) induced by adenine, this study explores the effects of growth hormone (GH) therapy on growth plate and mineral...
6.
Claramunt D, Gil-Pena H, Fuente R, Garcia-Lopez E, Loredo V, Hernandez-Frias O, et al.
Am J Physiol Renal Physiol
. 2015 May;
309(1):F57-62.
PMID: 25972508
Growth retardation is a major manifestation of chronic kidney disease (CKD) in pediatric patients. The involvement of the various pathogenic factors is difficult to evaluate in clinical studies. Here, we...
7.
Garcia-Marcos L, Valverde-Molina J, Pavlovic-Nesic S, Claret-Teruel G, Penalba-Citores A, Nehme-Alvarez D, et al.
Pediatr Pulmonol
. 2013 Oct;
49(10):1011-9.
PMID: 24167120
Background: How pediatricians manage bronchiolitis and the derived total costs (direct and indirect) in the emergency department (ED) have not been fully characterized. The aim of the present study is...
8.
Alvarez-Garcia O, Garcia-Lopez E, Loredo V, Gil-Pena H, Mejia-Gaviria N, Rodriguez-Suarez J, et al.
PLoS One
. 2012 Apr;
7(4):e34788.
PMID: 22493717
Rapamycin, an immunosuppressant agent used in renal transplantation with antitumoral properties, has been reported to impair longitudinal growth in young individuals. As growth hormone (GH) can be used to treat...
9.
Alvarez-Garcia O, Garcia-Lopez E, Loredo V, Gil-Pena H, Rodriguez-Suarez J, Ordonez F, et al.
Kidney Int
. 2010 Jun;
78(6):561-8.
PMID: 20555322
Rapamycin, a potent immunosuppressant used in renal transplantation, has been reported to impair longitudinal growth in experimental studies. Rapamycin is both antiproliferative and antiangiogenic; therefore, it has the potential to...
10.
Gil-Pena H, Garcia-Lopez E, Alvarez-Garcia O, Loredo V, Carbajo-Perez E, Ordonez F, et al.
Am J Physiol Renal Physiol
. 2009 Jul;
297(3):F639-45.
PMID: 19587145
Hypokalemic tubular disorders may lead to growth retardation which is resistant to growth hormone (GH) treatment. The mechanism of these alterations is unknown. Weaning female rats were grouped (n =...